Treating Acutely Agitated Patients With Asenapine Sublingual Tablets

NCT01400113 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

120

Enrollment

OTHER

Sponsor class

Conditions

Agitation

Interventions

DRUG: Asenapine
DRUG: Placebo

Sponsor

Unity Health Toronto

Collaborators

[object Object]